Sarah Kendroud, DO

Sarah Kendroud, DO

Neurology Resident Physician
Neurology

    About me

    Gender

    Female

    Education & training

    Positions
    Neurology Resident Physician
    Medical School
    Touro University College of Osteopathic Medicine, California
    Resident Program
    Neurology
    Resident Graduation Year
    2024
    Hometown
    San Ramon, California
    Hobbies
    Hiking, camping, running, traveling, reading, learning new languages.
    Interests: General Neurology and Movement Disorders
    Why they chose SIU

    I rotated as a visiting 4th year medical student in the neurology department and had a really meaningful and enriching learning experience during my one-month rotation at SIU.

    Clinical trials

    Trial
    Neuroscience Institute

    18-513: A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor XA Inhibitor

    Active not recruiting

    18-513:  The purpose of this study is to evaluate the effect of andexanet alfa (andexanet) versus usual care on the rate of effective homostasis.

    Contact: Stephanie Kohlrus 217-545-3013
    Trial
    Neurology

    Portola: A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor XA Inhibitor

    Active not recruiting

    ANNEXa-1 (18-513): This is a randomized, multicenter clinical trial designed to determine the efficacy and safety of andexanet compared to usual care in patients presenting with acute intracerebral hemorrhage within 6 hours of symptom onset (from the baseline scan) and within 15 hours of taking an oral FXa inhibitor (from randomization). The study will use a prospective, randomized, open-label design, as it is unfeasible to blind the Investigator to the treatment assignment given the many potential therapeutic options available under usual care treatment.

    Contact: Stephanie Kohlrus 217-545-3013